These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP). Liu T; Scallan CD; Broze GJ; Patarroyo-White S; Pierce GF; Johnson KW Thromb Haemost; 2006 Jan; 95(1):68-76. PubMed ID: 16543964 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions]. Sultan Y; Brouet JC Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682 [TBL] [Abstract][Full Text] [Related]
6. [Coagulopathy with autoantibodies to blood-clotting factors: overview and laboratory diagnosis]. Arai M Rinsho Byori; 2004 Feb; 52(2):178-81. PubMed ID: 15027324 [TBL] [Abstract][Full Text] [Related]
7. Advances in the treatment of inherited coagulation disorders. Escobar MA Haemophilia; 2013 Sep; 19(5):648-59. PubMed ID: 23600951 [TBL] [Abstract][Full Text] [Related]
8. Immune tolerance therapy in patients with acquired hemophilia. von Depka M Hematology; 2004 Aug; 9(4):245-57. PubMed ID: 15621732 [TBL] [Abstract][Full Text] [Related]
9. Acquired factor VIII inhibitor. Simpson WG; Neefe J; Zang J; Drosick R; Kearns R J Ky Med Assoc; 1991 Nov; 89(11):555-7. PubMed ID: 1748831 [TBL] [Abstract][Full Text] [Related]
13. Progress in the treatment of bleeding disorders. Bergman GE Thromb Res; 2011 Jan; 127 Suppl 1():S3-5. PubMed ID: 21035836 [TBL] [Abstract][Full Text] [Related]
14. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors. Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895 [TBL] [Abstract][Full Text] [Related]
15. Current concepts of hemostasis: implications for therapy. Roberts HR; Monroe DM; Escobar MA Anesthesiology; 2004 Mar; 100(3):722-30. PubMed ID: 15108990 [TBL] [Abstract][Full Text] [Related]
16. Coagulation disorders and inhibitors of coagulation in children from Mansoura, Egypt. Abdelrazik N; Rashad H; Selim T; Tharwat L Hematology; 2007 Aug; 12(4):309-14. PubMed ID: 17654057 [TBL] [Abstract][Full Text] [Related]
17. Hemostatic defect due to acquired circulating inhibitors against lipid procoagulant and factor VIII. Pechet L; Snyder LM; Chesney C; Colman RW Thromb Diath Haemorrh; 1974 Sep; 32(1):90-104. PubMed ID: 4548947 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors. Reipert BM; van Helden PM; Schwarz HP; Hausl C Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196 [TBL] [Abstract][Full Text] [Related]
20. Promising coagulation factor VIII bypassing strategies for patients with haemophilia A. Duan X; Tang M; Zhang J; Yu H; Xu R Blood Coagul Fibrinolysis; 2014 Sep; 25(6):539-52. PubMed ID: 24614429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]